<analysis>
**A1 (Apollo intake readiness).** This is internal plumbing: documenting channel definitions, testing scoring endpoints and integrating the harness. There is no negotiation, and the action correctly avoids pushing on Apollo. The main risks are the eval-compute squeeze (the GPT-7.5 comparison runs already pre-empted this work in December) and the usual integration bugs on a new interface. The action does not cover delays on Apollo's side of the pipeline.

**A2 (bio adjudication by 10 February).** This is standard procedure, but it needs a qualified third rater who is independent of sites 1 and 2 and cleared on the protocol. That person has to be found and scheduled inside a week. The biosafety officer is back but has a backlog from mid-January. Adjudication could also confirm disagreement, which would force session 3 to be excluded rather than recovered. The 10 February date is tight; slipping it by a few days would still leave 24 February reachable.

**A3 (CAISI instant engagement).** Anthropic controls the monitoring and the packet staging, so these are easy. Two parts depend on others:
- Confirming the queue position needs CAISI staff, and most of them are furloughed.
- A day-1 transmission only matters if funding resumes.

I am declaring the shutdown's end as an exogenous roll: **60% it ends in February**, matching last month's declared hazard. Execution risk on the action itself is modest. The risk that CAISI triages our filing downward belongs to T2 and is not double-counted here.

**A4 (March board materials).** This is a drafting task, but counsel will edit it again. The line "OpenAI's clearance validates the approach" is fragile: METR measured GPT-7.5 at 12.4 days, and the clearance came with light mitigations. Counsel also restated the GA date last month. The draft will almost certainly be finished; the risk is a late or diluted version. The March meeting itself is next month. For this month I am declaring the **acceleration directors circulating a pre-read or requesting an agenda item: 40%**. My preliminary P(motion in March) is about 25%, to be finalised next month.

**A5 (prototype checkpoint).** This is monitoring and is very likely to complete. The flaw in the handoff test set is a separate risk, handled by T3.

**Threats, briefly:**
- **T1:** Channel 2 is already failing statically, so it will very probably fail adaptively. The binding question is whether round 1 finishes and is communicated before 28 February, given plants only start on 3 February.
- **T2:** This can only materialise if reopening happens in February.
- **T3:** The gap is structural (no one holds external handoff plants), and a mid-February checkpoint is exactly where it would surface.
- **T4:** Gemini 7 is expected in 2030, but a February launch with no review, one month after Tri-Rivers, is a narrow window.
- **T5:** The copycat base rate is elevated, but public AI attribution took about 9 days last time, which makes an attribution inside the month harder.

**Declared exogenous rolls** (resolved in message 2 from these figures):
- **Shutdown ends in February:** 60%.
  - If it ends, the delayed December and January jobs reports are published within about 2 weeks: 85%.
- **Ohio death-review finding released in February:** 35%.
  - Given a finding, it links the death to the diversion: 55%.
- **Health-ISAC or a hospital partner asks Anthropic for defensive help:** 40%.
- **Substantive EU or UK open-weight reaction:** 55%. This means an AI Office statement or a code acceleration, or a UK NCSC advisory; a bare mention does not count.
- **Pro-open-weight rebuttal to Cruz from a notable voice (a16z, Meta or HF-adjacent):** 50%.
- **New METR or AISI frontier measurement published:** 10%.
- **Major DeepSeek or Kimi open release:** 10%.

**Capability clock.** With no new public release, the public tier holds at CI-5.38. The internal tier gains about 0.025–0.035.
</analysis>

<action_odds>
Action 1 [Apollo intake readiness]: P(failure) 12%. Reason: internal integration work with no external dependency; the residual risk is the eval-compute squeeze and endpoint bugs on a new interface.

Action 2 [Bio third-rater adjudication by Feb 10]: P(failure) 28%. Reason: an independent rater must be found and scheduled within a week, the biosafety officer is catching up on a backlog, and adjudication may confirm disagreement and force session 3 to be excluded; a slip past 10 February counts as partial.

Action 3 [CAISI instant engagement]: P(failure) 18%. Reason: monitoring and staging are in Anthropic's hands, but confirming the queue position needs furloughed CAISI staff; the payoff depends on the separate 60% shutdown-end roll, and triage risk sits in T2.

Action 4 [March board prep by Feb 20]: P(failure) 15%. Reason: routine drafting; the risk is a counsel rewrite that softens the "CAISI clearance validates" argument or pushes delivery past 20 February.

Action 5 [Handoff prototype checkpoint]: P(failure) 10%. Reason: this is a status check with both contractors active; the substantive test-set risk is modelled in T3.
</action_odds>

<threat_odds>
Threat 1 [Apollo round 1 breaks ch2]: P(materialises) 26%. Adversary suggested 30%; reason for any difference: a channel 2 fail is likely at about 70%, but a round-1 result reaching Anthropic inside February, with plants only starting on 3 February, is under 40%.

Threat 2 [Reopening doesn't reopen review]: P(materialises) 25%. Adversary suggested 40% conditional on reopening; reason for any difference: I use their conditional figure of about 42%, multiplied by the 60% chance of reopening in February, because the threat cannot materialise this month without reopening.

Threat 3 [Handoff prototype lacks valid test set]: P(materialises) 40%. Adversary suggested 35%; reason for any difference: the gap is structural (no one holds external handoff plants) and a mid-February checkpoint is exactly where it would be noticed, so I rate it slightly higher.

Threat 4 [Gemini 7 staged launch in Feb]: P(materialises) 12%. Adversary suggested 25%; reason for any difference: "2030" spans 11 months, and shipping with no review one month after Tri-Rivers is a reputational risk Google tends to avoid; a trusted-partner preview remains possible.

Threat 5 [Second AI-attributed hospital intrusion]: P(materialises) 24%. Adversary suggested 30%; reason for any difference: the copycat risk is elevated and CISA is degraded, but the incident needs both to happen and to be publicly attributed to open weights within the month, and attribution took about 9 days last time.
</threat_odds>
